Almi Invest and trade union Unionen have both returned with funding for Beactica, a drug discovery company based on Uppsala University research.

Beactica, a Sweden-based drug development company based on research from Uppsala University, has closed an oversubscribed round of undisclosed size featuring VC firm Almi Invest and trade union Unionen.

While none of the round’s other participants were named, more than a third of them were revealed to be new investors.

Founded in 2006, Beactica is pursuing drug discovery programs that pinpoint interactions between different molecules to support potential therapeutic applications. It also offers asset generation services to third-party labs, having…